Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: DATSCAN

Summary for Tradename: DATSCAN

Suppliers: see list1
patent expirations by year for

Clinical Trials for: DATSCAN

Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
Status: Completed Condition: Lewy Body Dementia

DaTSCAN Imaging in Aging and Neurodegenerative Disease
Status: Enrolling by invitation Condition: Dementia; Parkinsonism; Mild Cognitive Impairment; REM Sleep Behavior Disorder

A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
Status: Completed Condition: Parkinsonian Syndromes

Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies
Status: Completed Condition: Dementia With Lewy Bodies

Validation of DaTscan for Detection of Parkinson Disease Related Disorders
Status: Enrolling by invitation Condition: Parkinson Disease; Movement Disorders

Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET)
Status: Active, not recruiting Condition: Essential Tremor; Parkinson's Disease

Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls
Status: Recruiting Condition: Amyotrophic Lateral Sclerosis

Co-LEsions in Alzheimer Disease and Related Disorders
Status: Not yet recruiting Condition: Alzheimer's Disease; Cerebrovascular Disease; Lewy Body Disease

Dopaminergic Loss and Pain in Parkinson's Disease
Status: Completed Condition: Parkinson's Disease; Pain

Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Status: Completed Condition: Lewy Body Dementia; Non-DLB Dementia; Alzheimer’s; Vascular Dementia

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Hlthcare Inc
ioflupane i-123
SOLUTION;INTRAVENOUS022454Jan 14, 2011RXYes<disabled><disabled>
Ge Hlthcare Inc
ioflupane i-123
SOLUTION;INTRAVENOUS022454Jan 14, 2011RXYes5,310,912<disabled>Y<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology